Jose López-Barneo

Institute of Biomedicine of Seville (IBIS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla

Acute oxygen sensing in health and disease

Julian Grünewald

Technical University of Munich

Engineered CRISPR prime editors with compact, untethered reverse transcriptases

Pilar Puig-Serra

CNIO, Madrid

Targeting and detection of cancer fusion oncogenes using CRISPR/Cas13

Annarita Miccio

Imagine Institute, Paris

Genome editing approaches for beta-hemoglobinopathies

Gloria González-Aseguinolaza

Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona

Liver gene-editing based on nickase cas9 for the treatment of Primary Hiperoxaluria type I (PH1) is more efficient when using an all-in-one delivery system

Jordi Barquinero

Vall d'Hebron Research Institute, Barcelona

In vivo gene editing for Mitochondrial NeuroGastroIntestinal Encephalomyopathy

Laurent Poirot

Cellectis

Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality

JuanRo Rodríguez

CIMA Universidad de Navarra

Genome editing for improved allogeneic CAR-T cells

Anastasia Conti

SR Tiget, Milan

Mechanistic insights into the response of Hematopoietic Stem Cells to Gene Editing

Pilar Martin-Duque

Universidad de Zaragoza

Use and isolation of maternal milk exosomes: New vector for genetic hNIS therapy and diagnostic in oncology.

Carlos Blanco-Benitez

LentiStem Biotech. GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government.PTS Granada

Lent-On-Plus: An all-in-one transactivator-free doxycycline inducible LVs ready for clinical applications.

Beatriz Fernandez-Muñoz

Red Andaluza de Diseño y Traslación de Terapias Avanzadas, Sevilla

Using organoids to evaluate safety and potency of cell therapies